Hyperphosphatemia Treatment Market Size | Is Projected to Reach USD 3.53 Billion in 2028 with CAGR 5.3%

NEXT STORY
Nunzia Pharmaceutical Corporation (OTC: NUNZ), an Emerging Leader in Innovative Pharmaceutical and Nutraceuticals, is Now Offering a Patented Blood Warmer Through Nunzia’s Medical Supply Division. 8K Filed 08/05/2021
PREV STORY
Inagene and Aspiria team up to improve mental health care for post-secondary students
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Summit Therapeutics Reports Financial Results and Operational Progress for the Second Quarter and Six Months Ended June 30, 2021

author_avatar
NASDAQ Market News

Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products

SAN ANTONIO, Feb. 21, 2018 (GLOBE NEWSWIRE) -- Mission Pharmacal Company (“Mission”) announced today ...

author_avatar
NASDAQ Market News

JUPITER MEDICAL CENTER IS FIRST HOSPITAL IN SOUTHEASTERN U.S. TO USE SPINEJACK®

author_avatar
NASDAQ Market News